Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

Core Viewpoint - Pfizer Inc. (PFE) is currently undervalued, trading at 8-9 times forward earnings, but there are strong indicators suggesting a potential comeback for the company [1]. Group 1 - The trading price of Pfizer is around $25, indicating a low valuation compared to its earnings potential [1]. - The insights are supported by Alfred Marcus, a professor at the University of Minnesota, who has authored multiple books on strategy and management [1]. - The article emphasizes the possibility of great companies, like Pfizer, rising again despite current market perceptions [1].